SE7900493L - Interferon och interforonhaltiga beredningar - Google Patents

Interferon och interforonhaltiga beredningar

Info

Publication number
SE7900493L
SE7900493L SE7900493A SE7900493A SE7900493L SE 7900493 L SE7900493 L SE 7900493L SE 7900493 A SE7900493 A SE 7900493A SE 7900493 A SE7900493 A SE 7900493A SE 7900493 L SE7900493 L SE 7900493L
Authority
SE
Sweden
Prior art keywords
interferon
cells
present
preventing
treating
Prior art date
Application number
SE7900493A
Other languages
English (en)
Other versions
SE436969B (sv
Inventor
K Sugimoto
S Yuen
Original Assignee
Hayashibara Ken
Ashida Shin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP536878A external-priority patent/JPS5498307A/ja
Priority claimed from JP13402678A external-priority patent/JPS5562024A/ja
Application filed by Hayashibara Ken, Ashida Shin filed Critical Hayashibara Ken
Publication of SE7900493L publication Critical patent/SE7900493L/sv
Publication of SE436969B publication Critical patent/SE436969B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE7900493A 1978-01-22 1979-01-19 Sett att framstella humanspecifikt interferon SE436969B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP536878A JPS5498307A (en) 1978-01-22 1978-01-22 Production of interferon
JP13402678A JPS5562024A (en) 1978-10-31 1978-10-31 Preventive and remedy for interferon-sensitive disease

Publications (2)

Publication Number Publication Date
SE7900493L true SE7900493L (sv) 1979-07-23
SE436969B SE436969B (sv) 1985-02-04

Family

ID=26339293

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7900493A SE436969B (sv) 1978-01-22 1979-01-19 Sett att framstella humanspecifikt interferon

Country Status (14)

Country Link
US (1) US4276282A (sv)
AU (1) AU533201B2 (sv)
CA (1) CA1135186A (sv)
CH (1) CH637831A5 (sv)
DE (1) DE2902136C2 (sv)
DK (1) DK153848C (sv)
ES (1) ES477060A1 (sv)
FI (1) FI66428C (sv)
FR (1) FR2414920A1 (sv)
GB (1) GB2016015B (sv)
IT (1) IT1116493B (sv)
NL (1) NL192086C (sv)
NO (1) NO152976C (sv)
SE (1) SE436969B (sv)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
JPS55122717A (en) * 1979-03-15 1980-09-20 Asai Gerumaniumu Kenkyusho:Kk Interferon inducer
EP0039325A1 (de) * 1979-10-19 1981-11-11 ROMANO, Amalia Mittel zur behandlung von virusinfektionen des auges und anderer organe
US4328207A (en) * 1979-12-27 1982-05-04 Ken Hayashibara Process for preparing mouse interferon
US4396601A (en) * 1980-03-26 1983-08-02 The Regents Of The University Of Calif. Gene transfer in intact mammals
US4497796A (en) * 1980-03-26 1985-02-05 The Regents Of The University Of California Gene transfer in intact mammals
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
JPS5826317B2 (ja) * 1980-12-30 1983-06-02 株式会社 林原生物化学研究所 ヒト甲状腺刺激ホルモンの製造方法
JPS5739795A (en) * 1980-08-22 1982-03-05 Hayashibara Biochem Lab Inc Preparation of human prolactin
JPS5729294A (en) * 1980-07-30 1982-02-17 Hayashibara Biochem Lab Inc Preparation of human insulin
JPS6045850B2 (ja) * 1980-12-13 1985-10-12 株式会社林原生物化学研究所 ヒト副腎皮質刺激ホルモンの製法
JPS5825439B2 (ja) * 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒト副甲状腺ホルモンの製造方法
JPS6045848B2 (ja) * 1980-07-31 1985-10-12 株式会社林原生物化学研究所 ヒト成長ホルモンの製造方法
JPS5825440B2 (ja) * 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒトカルシトニンの製造方法
JPS6045851B2 (ja) * 1980-12-19 1985-10-12 株式会社林原生物化学研究所 ヒト胎盤性ラクトゲンの製造方法
US4462985A (en) * 1980-08-22 1984-07-31 University Of Illinois Foundation Delivery of biologically active components of heterologous species interferon isolates
JPS586475B2 (ja) * 1980-08-23 1983-02-04 株式会社 林原生物化学研究所 ヒト絨毛性性腺刺激ホルモンの製造方法
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
JPS585671B2 (ja) * 1980-08-27 1983-02-01 株式会社 林原生物化学研究所 ヒト卵胞刺激ホルモンの製造方法
JPS5743696A (en) * 1980-08-27 1982-03-11 Hayashibara Biochem Lab Inc Preparation of human luteinizing hormone
JPS5852634B2 (ja) * 1980-12-05 1983-11-24 株式会社林原生物化学研究所 ウロキナ−ゼの製造法
JPS609795B2 (ja) * 1980-12-11 1985-03-13 株式会社林原生物化学研究所 ヒト上皮細胞成長因子の製造方法
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
JPS6030657B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒト細胞増殖促進因子の製造方法
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
DE3249946C2 (de) * 1981-07-21 1996-03-21 Hayashibara Biochem Lab hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung
EP0090837A1 (en) * 1981-10-08 1983-10-12 BERG, Kurt Frimann Method and composition for treating a patient suffering from interferonsusceptible disorder
US4675295A (en) * 1981-10-28 1987-06-23 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing subculturable lymphokine-producing human T cell hybridomas
JPS58126786A (ja) * 1982-01-25 1983-07-28 Hayashibara Biochem Lab Inc ヒトカリクレインの製造方法
JPS58138395A (ja) * 1982-02-12 1983-08-17 Hayashibara Biochem Lab Inc ヒト免疫応答抑制因子の製造方法
US4624917A (en) * 1982-02-17 1986-11-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human T-cell growth factor
US4987079A (en) * 1982-07-06 1991-01-22 Wilbur D. Smith Composition and method for in vitro cell culture
WO1984000775A1 (en) * 1982-08-10 1984-03-01 Univ Columbia The use of eucaryotic promoter sequences in the production of proteinaceous materials
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4870009A (en) * 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4489163A (en) 1983-04-14 1984-12-18 The Salk Institute For Biological Studies rCRF and analogs
WO1984004887A1 (en) * 1983-06-13 1984-12-20 Ragnvald Erik Lindblom A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A gamma-INTERFERON CONTAINING PREPARATION
US4680174A (en) * 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US5175385A (en) * 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
JPH0665297A (ja) * 1992-08-21 1994-03-08 Hayashibara Biochem Lab Inc メラニン合成抑制蛋白質とその製造方法並びに用途
EP0619120B1 (en) * 1993-04-09 2002-09-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Use of human interferon-alpha for the manufacture of a medicament for treatment of respiratory disease in cats
JP4004088B2 (ja) * 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
US5723718A (en) * 1994-12-20 1998-03-03 St. Joseph's Hospital And Medical Center Induction of immune tolerance to tumor cells
US5939286A (en) * 1995-05-10 1999-08-17 University Of Florida Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
US6204022B1 (en) 1996-04-12 2001-03-20 Pepgen Corporation And University Of Florida Low-toxicity human interferon-alpha analogs
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素
TW515843B (en) * 1996-07-25 2003-01-01 Hayashibara Biochem Lab Process for producing an active polypeptide inducing interferon-γ production
US6514728B1 (en) * 1998-11-09 2003-02-04 Nippon Biocaptal Limited Process for preparation of cytokines using Sendai virus expression system
EP1092773A3 (en) * 1999-10-15 2001-08-08 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Polypeptide and uses thereof
JP2002201141A (ja) 2000-10-27 2002-07-16 Hayashibara Biochem Lab Inc 蛋白質合成抑制遺伝子の発現増強剤
WO2003016472A2 (en) * 2001-08-12 2003-02-27 Pepgen Corporation Hybrid interferon/interferon tau proteins, compositions and methods of use
CA2911613A1 (en) 2013-03-29 2014-10-02 Centre National De La Recherche Scientifique (Cnrs) Cgrp receptor agonist for hiv treatment or prevention
WO2015140348A2 (en) 2014-03-21 2015-09-24 Centre National De La Recherche Scientifique (Cnrs) Use of dj-1 deglycase activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6914761D0 (pt) * 1969-01-17 1973-03-08 Merck & Co Inc Processos quimicos

Also Published As

Publication number Publication date
FI66428C (fi) 1984-10-10
NO790195L (no) 1979-07-24
CA1135186A (en) 1982-11-09
DK25579A (da) 1979-07-23
US4276282A (en) 1981-06-30
CH637831A5 (fr) 1983-08-31
NO152976B (no) 1985-09-16
GB2016015A (en) 1979-09-19
FI66428B (fi) 1984-06-29
NO152976C (no) 1985-12-27
FR2414920A1 (fr) 1979-08-17
FI790188A (fi) 1979-07-23
NL192086C (nl) 1997-02-04
GB2016015B (en) 1982-05-06
DE2902136C2 (de) 1986-09-04
FR2414920B1 (sv) 1982-08-06
IT1116493B (it) 1986-02-10
SE436969B (sv) 1985-02-04
AU533201B2 (en) 1983-11-10
DE2902136A1 (de) 1979-08-09
DK153848C (da) 1989-04-03
AU4334579A (en) 1979-08-02
ES477060A1 (es) 1979-12-16
NL7900476A (nl) 1979-07-24
NL192086B (nl) 1996-10-01
IT7947712A0 (it) 1979-01-19
DK153848B (da) 1988-09-12

Similar Documents

Publication Publication Date Title
SE7900493L (sv) Interferon och interforonhaltiga beredningar
SE8000243L (sv) Typ ii-interferon och medel innehallande detsamma
DK319481A (da) Fremgangsmaade til fremstilling af forbindelse indeholdende 2-phenyl-1,2-benzioselenazol-3(2h)-on
ES471721A1 (es) Un procedimiento para producir interferon
DE69003652D1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
JPS57105191A (en) Production of human urogastrone
SE7908516L (sv) Sett att framstella ett bakteriostatiskt material
ATE6871T1 (de) Verfahren zur herstellung oder zur biologischen umsetzung von stoffwechselprodukten mittels pflanzlicher zellen in vitro.
FR2391733A1 (fr) Antigene contre les tumeurs et son procede de preparation
JPS5729294A (en) Preparation of human insulin
ES444311A1 (es) Un procedimiento de lisis del residuo micelar obtenido en laproduccion de antibioticos.
ATE21119T1 (de) Verfahren zur herstellung von 3-oxo-delta-1,4steroiden.
SE7608103L (sv) Forfarande for behandling av cellprotein
DK299981A (da) Fremgangsmaade til fremstilling af 1-s-alkyl-2-0-acyl-3-phosphocolin-1-mercapto-2.3-propandioler
JPS5245277A (en) Method for production of complementary mis-ic
UA7014A1 (uk) Спосіб отримання 4-аміно-5-хлор-1-фенілпірідазона-(6)
JPS51125787A (en) Method for cultivating and processing of mashrooms
JPS5236572A (en) Treating method of waste fluid from mandarine orange factory for the p urpose of obtaining resources
SE7607909L (sv) Forfarande for framstellning av bioproteiner med hjelp av mikroorganismer samt mikroorganismer for detta endamal
DE2862004D1 (en) Treatment of herbicid containing cultures with derivatives of dichloroacetamide or of thrichloroacetamide, novel derivatives of dichloroacetamide or trichloroacetamide and process for their preparation
ATE18256T1 (de) Antianaemische zusammensetzung und verfahren zu deren herstellung.
GB1492441A (en) Confirming a desired heat effect on a material
ATE11568T1 (de) Verfahren zur herstellung von 11-alpha-hydroxy-20-alpha-hydroxymethyl-1,4-pre nadien-3-on.
JPS533578A (en) Preparation of gel-forming microbial cells
JPS56121497A (en) Preparation of polysaccharide

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7900493-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7900493-3

Format of ref document f/p: F